W. Bowman

发表

Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia

M. Loh, M. Relling, Cheng Cheng, 2011, Nature Genetics.

Association of GATA3 polymorphisms with minimal residual disease and relapse risk in childhood acute lymphoblastic leukemia.

M. Loh, M. Relling, Cheng Cheng, 2020, Journal of the National Cancer Institute.

Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia

M. Relling, Cheng Cheng, C. Pui, 2011, Leukemia.

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Elaine Coustan-Smith, Dario Campana, Xueyuan Cao, 2010, The Lancet. Oncology.

Treating childhood acute lymphoblastic leukemia without cranial irradiation.

Cheng Cheng, Elaine Coustan-Smith, Dario Campana, 2009, The New England journal of medicine.

Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels.

J. Downing, S. Raimondi, M. Relling, 2015, Blood.

Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia.

M. Relling, C. Pui, W. Evans, 2009, NCI monographs : a publication of the National Cancer Institute.

Methotrexate cerebrospinal fluid and serum concentrations after intermediate‐dose methotrexate infusion

W. Evans, C. Stewart, W. Bowman, 1983, Clinical pharmacology and therapeutics.

Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.

C. Croce, M. Negrini, C. Felix, 1993, Cancer research.

Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation

D. Eslin, R. Basha, J. Vishwanatha, 2015, International Journal of Developmental Neuroscience.

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

J. Downing, S. Raimondi, M. Relling, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safe laparoscopic cholecystectomy in a community setting, N=762

W. Bowman, S. Blievernicht, W. Weatherly, 1993, Surgical Endoscopy.

Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X.

C. Pui, W. Evans, D. Williams, 1992, Leukemia.

Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia

D. Campana, C. Pui, R. Ribeiro, 2013, Cancer.

Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia.

C. Pui, A. Look, P. Roberson, 1985, Blood.

Near-haploid acute lymphoblastic leukemia: a unique subgroup with a poor prognosis?

A. Look, G. Brodeur, W. Bowman, 1981, Blood.

Genome-wide Analysis Links Nfatc2 with Asparaginase Hypersensitivity Key Points

M. Loh, M. Relling, C. Pui, 2022 .

Acute lymphocytic leukemia: Biological markers of clinical response

A. Look, W. Bowman, W. Bowman, 1982, Journal of cellular physiology. Supplement.

Childhood acute lymphocytic leukemia: progress and problems in treatment.

W. Bowman, 1981, Canadian Medical Association journal.

Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy

J. Downing, S. Shurtleff, S. Raimondi, 2015, British journal of haematology.

The role of cell markers in the management of leukemia.

W. Bowman, A. Mauer, 1981, Progress in hematology.

Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor

A. Bernard, L. Boumsell, W. Bowman, 1982 .

Lipoperoxidation and T‐cell leukemia of childhood. Effects of indomethacin

Ming-chi Wu, W. Bowman, M. Wu, 1989, Cancer.

Early Nutrition Intervention Attenuates Weight Gain for Pediatric Acute Lymphoblastic Leukemia Patients in Maintenance Therapy

W. Bowman, L. Bashore, R. Hill, 2017, Journal of pediatric hematology/oncology.

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect.

S L George, A T Look, C. Pui, 1986, The New England journal of medicine.

Serum vitamin A status in acute lymphocytic leukemia of childhood.

W. Bowman, R. Brown, S. Alade, 1988, Annals of clinical and laboratory science.

Progress against childhood cancer: the Pediatric Oncology Group experience.

J. Krischer, L. Frankel, J. Shuster, 1992, Pediatrics.

Minimal Residual Disease–Directed Therapy for Childhood Acute Myeloid Leukemia: Results of the AML02 Multicenter Trial.

D. Campana, C. Pui, S. Meshinchi, 2009 .

Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine.

C. Pui, C. Chesney, W. Bowman, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia.

Elaine Coustan-Smith, Dario Campana, Xueyuan Cao, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.

W. Bowman, G. Dahl, S. Melvin, 1981, Cancer research.

Serum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemia.

C. Pui, A. Look, W. Bowman, 1985, Blood.

Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia.

S L George, C. Pui, S. George, 1984, Cancer research.

Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia.

A. Look, M. Danks, W. Bowman, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.

M. Loh, M. Relling, C. Pui, 2014, Blood.

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.

Cheng Cheng, Dario Campana, Paul Scheet, 2012, Blood.

Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.

M. Diccianni, A. Batova, R. Chang, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.

S. Raimondi, M. Relling, Cheng Cheng, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted Nanoparticles for Pediatric Leukemia Therapy

R. Basha, N. Sabnis, A. Lacko, 2014, Front. Oncol..

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.

C. Pui, D. Fairclough, C. Berard, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.

D. Eslin, J. Murray, R. Basha, 2019, Gene.

Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia.

C. Pui, M. Costlow, W. Bowman, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy.

W. Bowman, W. Bowman, L. Ch'ien, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

M. Loh, M. Relling, Cheng Cheng, 2013, Nature Genetics.

Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy.

C. Pui, R. Dodge, W. Bowman, 1988, Medical and pediatric oncology.

Second central nervous system prophylaxis in children with acute lymphoblastic leukemia who relapse after elective cessation of therapy.

S. George, W. Bowman, G. Rivera, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship of pretreatment lymphoblast proliferative activity and prognosis in 97 children with acute lymphoblastic leukemia.

A. Tsiatis, W. Bowman, L. Dow, 1982, Blood.

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy

S. Shurtleff, S. Raimondi, M. Relling, 2012, Leukemia.

Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy

Pui, J. Downing, S. Raimondi, 2016, Leukemia.

Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis. Reversal with VP‐16 and indomethacin

W. Bowman, J. Champion, R. Brown, 1987, Cancer.

Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.

J. Downing, M. Relling, Cheng Cheng, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells

D. Eslin, R. Basha, Sangram Raut, 2019, Apoptosis.

Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.

Cheng Cheng, Elaine R Mardis, Ching-Hon Pui, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

J. Downing, M. Relling, Cheng Cheng, 2015, The Lancet. Oncology.

Effect of body mass index on the outcome of children with acute myeloid leukemia

Dario Campana, Xueyuan Cao, Ching-Hon Pui, 2012, Cancer.

ELECTIVE TESTICULAR BIOPSY DURING CHEMOTHERAPY FOR CHILDHOOD LEUKAEMIA IS OF NO CLINICAL VALUE

C. Pui, W. Bowman, G. Rivera, 1985, The Lancet.

Pleuropulmonary Blastoma: A Single-center Case Series of 6 Patients

L. Margraf, W. Bowman, K. Heym, 2017 .

Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor.

A. Bernard, J. Caillaud, L. Boumsell, 1982, Blood.

Volume depletion of bone marrow using gravity sedimentation in hydroxyethyl starch for the pediatric allogeneic transplant patient.

W. Bowman, L. Wood, D. J. Friedman, 1992, Progress in clinical and biological research.

Isolated testicular relapse in acute lymphocytic leukemia of childhood: categories and influence on survival.

R. Aur, W. Bowman, W. Bowman, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia.

M. Relling, Cheng Cheng, D. Campana, 2012, Blood.

Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia.

W. Bowman, G. Rivera, J. Ochs, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group study.

R. Parmley, B. Pollock, C. Pratt, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cell markers in lymphomas and leukemias.

W. Bowman, A. Mauer, S. Melvin, 1980, Advances in internal medicine.

A clinical perspective on cell markers in acute lymphocytic leukemia.

R. Aur, W. Bowman, A. Mauer, 1981, Cancer research.

Identification of a leukemia-associated antigen of human acute lymphocytic leukemia.

W. Bowman, S. Melvin, B. Veit, 1980, Journal of the National Cancer Institute.

Recent results from Total Therapy Study X for standard and high risk acute lymphoblastic leukemia in children: recognition of new clinical and biologic risk features.

C. Pui, W. Evans, A. Look, 1985, Haematology and blood transfusion.

Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.

M. Loh, M. Relling, C. Pui, 2015, Blood.

VM26 therapy in children with drug-refractory lymphocytic leukemia

W. Bowman, G. Rivera, S. Murphy, 2004, Cancer Chemotherapy and Pharmacology.

VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.

R. Aur, W. Bowman, S. Murphy, 1982, Medical and pediatric oncology.

Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone.

C. Pui, R. Aur, G. Burghen, 1981, The Journal of pediatrics.

Universal cholesterol screening of children in community-based ambulatory pediatric clinics.

W. Bowman, C. McNeal, V. Leung-Pineda, 2015, Journal of clinical lipidology.

Correlation of Lipid Profile and Risk of Developing Type 2 Diabetes Mellitus in 10-14 Year Old Children

R. Basha, W. Bowman, K. Fulda, 2016, Cellular Physiology and Biochemistry.

Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells

D. Eslin, R. Basha, Sangram Raut, 2019, Apoptosis.

Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood.

W. Evans, A. Look, W. Bowman, 1982, Cancer treatment reviews.

Disposition of Intermediate-Dose Methotrexate in Children with Acute Lymphocytic Leukemia

W. Evans, C. Stewart, G. Yee, 1982, Drug intelligence & clinical pharmacy.

Central Nervous System Prophylaxis for Therapy of Acute Lymphocytic Leukemia

W. Evans, W. Bowman, A. Mauer, 1983 .

in acute lymphoblastic leukemia Dexamethasone exposure and asparaginase antibodies affect relapse risk

Cheng Cheng, C. Pui, W. Evans, 2011 .

Educational attainment in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).

A. King, G. Armstrong, D. Srivastava, 2019, Journal of Clinical Oncology.

A comparison of varus and valgus slipped capital femoral epiphysis: A case series

W. Bowman, James B. Meiling, M. Mayfield, 2018 .

Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia.

W. Bowman, W. Bowman, G. Buchanan, 1983, The Journal of pediatrics.

Pleuropulmonary Blastoma: A Single-center Case Series of 6 Patients.

L. Margraf, W. Bowman, K. Heym, 2017, Journal of pediatric hematology/oncology.

A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia

J. Downing, S. Raimondi, M. Relling, 2014, Leukemia.

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

J. Downing, M. Relling, Cheng Cheng, 2015, The Lancet. Oncology.

Mentors’ experiences in an osteopathic medical student research program

R. Basha, W. Bowman, D. Wilson, 2021, Journal of osteopathic medicine.